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This article is protected by copyright. All rights reserved. expansion of T lymphocytes. The first case (patient #1) is a child treated with AMX/CLV during EBV infection, and the second case (patient #2) is a child treated with AMX/CLV where other possible diseases were ruled out.
Patient #1 is a Caucasian boy who had already used oral AMX/CLV to treat common upper airway infectious diseases. At three years of age, he was treated with oral AMX/CLV syrup for an acute febrile pharyngitis (39.8°C) and lymphadenopathy that was later diagnosed as EBV infection by serological tests. On the third day, he was evaluated at the emergency department of Anna Meyer Children Hospital, where he appeared in poor general condition with fever (38.5°C), malaise, generalized maculopapular exanthema (MPE) with purpuric lesions covering the entire body surface plus both plantar and palmar regions, redness of the eyes, oral erosions of the lips, throat hyperemia, and cervical lymphadenopathy. According to these clinical symptoms, he was diagnosed as being affected by SJS due to the treatment with AMX/CLV during EBV infection. The drug was stopped and he received supportive therapies, including a short course of corticosteroids, fluid replacement with electrolyte solution and analgesic therapy, and recovered within 10 days. Six months later, he was referred to the Allergy Unit of Anna Meyer children's hospital for an allergologic work-up.
According to the European Network for Drug Allergy (ENDA) diagnostic algorithm for in vivo allergologic evaluation of non-immediate reaction to β-lactams, patch tests and skin intradermal tests (ID) with AMX/CLV were consecutively performed (6) . Patch tests at 5 and 20% in petrolatum were tested, with negative readings 15 minutes after removal of the strips and 24-48 hours later (7) . Intradermal testing with AMX/CLV at 2-20 mg/ml concentrations was also negative (including delayed readings at 24, 48 and 72 hours). Positive and negative controls for SPT and ID were obtained using histamine (ALK-Abellò, Milan, Italy: 10 and 1 mg/mL) and normal saline. A positive Patch test was defined as when an infiltrate was
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